These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1445954)

  • 21. Transdermal scopolamine-induced neurologic deficits in patients with cancer.
    Friedberg MH; Glantz MJ
    R I Med; 1994 May; 77(5):141-2. PubMed ID: 8019013
    [No Abstract]   [Full Text] [Related]  

  • 22. Transdermal scopolamine patches reduce postoperative emesis in pediatric patients undergoing strabismus surgery.
    Horimoto Y; Naide M
    Can J Anaesth; 1990 May; 37(4 Pt 2):S94. PubMed ID: 2193765
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch.
    Roberge RJ
    J Emerg Med; 2006 Apr; 30(3):299-302. PubMed ID: 16677982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study.
    Reinhart DJ; Klein KW; Schroff E
    Anesth Analg; 1994 Aug; 79(2):281-4. PubMed ID: 7639364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An unusual case of psychosis caused by long-term administration of a scopolamine membrane patch. Paranoid hallucinogenic and delusional symptoms].
    Rubner O; Kummerhoff PW; Haase H
    Nervenarzt; 1997 Jan; 68(1):77-9. PubMed ID: 9132625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of short-term retrievable ureteral stent in pediatric laparoscopic pyeloplasty.
    Yucel S; Samuelson ML; Nguyen MT; Baker LA
    J Urol; 2007 Feb; 177(2):720-5; discussion 725. PubMed ID: 17222666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative Anticholinergic Poisoning: Concealed Complications of a Commonly Used Medication.
    Zhang XC; Farrell N; Haronian T; Hack J
    J Emerg Med; 2017 Oct; 53(4):520-523. PubMed ID: 28756934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of scopolamine in the treatment of detrusor instability.
    Muskat Y; Bukovsky I; Schneider D; Langer R
    J Urol; 1996 Dec; 156(6):1989-90. PubMed ID: 8911372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scopolamine: new preparations. Reference treatment for death rattle.
    Prescrire Int; 2001 Aug; 10(54):99-101. PubMed ID: 11718188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual side-effects from transdermal scopolamine (hyoscine).
    Firth AY; Walker K
    Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anisocoria from transdermal scopolamine.
    Lin YC
    Paediatr Anaesth; 2001; 11(5):626-7. PubMed ID: 11696132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal nicotine for analgesia after radical retropubic prostatectomy.
    Habib AS; White WD; El Gasim MA; Saleh G; Polascik TJ; Moul JW; Gan TJ
    Anesth Analg; 2008 Sep; 107(3):999-1004. PubMed ID: 18713920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron.
    Jones S; Strobl R; Crosby D; Burkard JF; Maye J; Pellegrini JE
    AANA J; 2006 Apr; 74(2):127-32. PubMed ID: 16617916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double blind comparison of transdermal hyoscine and placebo for the prevention of postoperative nausea.
    Koski EM; Mattila MA; Knapik D; Toivanen T; Ruusukallio H; Andersson P; Freudenthal Y
    Br J Anaesth; 1990 Jan; 64(1):16-20. PubMed ID: 2405893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of drooling using transdermal scopolamine skin patches. A case report.
    Mato Montero A; Limeres Posse J; Tomás Carmona I; Fernández Feijoo J; Diz Dios P
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E27-30. PubMed ID: 18167476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal scopolamine use in the control of narcotic-induced nausea.
    Ferris FD; Kerr IG; Sone M; Marcuzzi M
    J Pain Symptom Manage; 1991 Aug; 6(6):389-93. PubMed ID: 1880439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal scopolamine-induced psychosis.
    Ziskind AA
    Postgrad Med; 1988 Sep; 84(3):73-6. PubMed ID: 2901077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scopolamine patch can be confusing to the patient and anesthesiologist: a case report.
    Elias MA; Abouleish E
    Anesthesiology; 1997 Mar; 86(3):743-4. PubMed ID: 9066342
    [No Abstract]   [Full Text] [Related]  

  • 40. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.